First patient enrolled globally in SELUTION SLR study for AV fistulae

Selution SLR MedAlliance has announced enrolment of the first patient in the SAVE (Use of the Selution sirolimus-eluting balloon for dysfunctional AV access treatment indications) study utilising their novel sirolimus-eluting balloon, for the treatment of failed arteriovenous (AV) fistulae in renal dialysis patients. The objectives of this prospective, randomised, single-blind multicentre study [...]

2020-04-16T13:42:19+00:00April 16th, 2020|Tags: , , |

Enrolment completed in US trial of VasQ external support

Laminate Medical Technologies has announced the completion of enrolment into the VasQ External Support US study.  The study was conducted at 17 sites across the USA and prospectively enrolled 144 male and female patients in need of an arteriovenous fistula (AVF) for haemodialysis. Both brachiocephalic and radiocephalic AVF patients were included in the study. [...]

2020-02-10T13:49:41+00:00February 10th, 2020|Tags: , , |

FDA approval of IN.PACT AV is a boon for management of dysfunctional AVFs

Andrew Holden Recently, the FDA approved Medtronic’s paclitaxel-coated balloon IN.PACT AV for the management of failing arteriovenous fistulae (AVF). Approval for the device was based on data from the IN.PACT AV Access trial, which showed the device to significantly increase primary patency compared with standard percutaneous transluminal angioplasty. Andrew Holden (Department of [...]